Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Stock Has Consensus Price Target of $22.23 According to Analysts

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) have received an average rating of “Moderate Buy” from the fourteen research firms that are presently covering the company, MarketBeat Ratings reports. Seven research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $22.23.

Several analysts have recently commented on SBRA shares. Huntington started coverage on Sabra Healthcare REIT in a research report on Thursday, September 10th. They issued an “outperform” rating and a $23.00 target price for the company. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. UBS Group set a $25.00 price objective on Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Raymond James Financial upgraded Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research report on Thursday, August 6th. Finally, Wall Street Zen raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th.

Insiders Place Their Bets

In other Sabra Healthcare REIT news, CEO Richard Matros sold 200,000 shares of the stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total value of $4,166,000.00. Following the completion of the sale, the chief executive officer owned 1,657,686 shares in the company, valued at $34,529,599.38. This represents a 10.77% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.09% of the company’s stock.

Hedge Funds Weigh In On Sabra Healthcare REIT

Institutional investors and hedge funds have recently modified their holdings of the stock. Principal Financial Group Inc. raised its holdings in shares of Sabra Healthcare REIT by 0.4% during the first quarter. Principal Financial Group Inc. now owns 25,052,121 shares of the real estate investment trust’s stock worth $481,755,000 after acquiring an additional 98,770 shares in the last quarter. Geode Capital Management LLC grew its stake in Sabra Healthcare REIT by 2.9% in the fourth quarter. Geode Capital Management LLC now owns 7,018,556 shares of the real estate investment trust’s stock valued at $132,949,000 after purchasing an additional 198,118 shares in the last quarter. Lasalle Investment Management Securities LLC grew its stake in Sabra Healthcare REIT by 8.2% in the first quarter. Lasalle Investment Management Securities LLC now owns 3,824,622 shares of the real estate investment trust’s stock valued at $73,547,000 after purchasing an additional 290,405 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Sabra Healthcare REIT by 7.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,725,337 shares of the real estate investment trust’s stock valued at $71,640,000 after buying an additional 269,793 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. grew its stake in shares of Sabra Healthcare REIT by 6.8% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,208,600 shares of the real estate investment trust’s stock valued at $61,701,000 after buying an additional 203,226 shares in the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Price Performance

SBRA stock opened at $19.85 on Friday. Sabra Healthcare REIT has a one year low of $17.17 and a one year high of $22.77. The firm has a 50-day moving average of $20.72 and a two-hundred day moving average of $20.17. The firm has a market capitalization of $5.07 billion, a PE ratio of 76.35, a P/E/G ratio of 1.50 and a beta of 0.65. The company has a current ratio of 3.07, a quick ratio of 3.07 and a debt-to-equity ratio of 0.95.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing the consensus estimate of $0.17 by ($0.27). Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The firm had revenue of $230.11 million during the quarter, compared to analysts’ expectations of $219.39 million. During the same quarter last year, the company posted $0.38 EPS. The firm’s revenue was up 24.7% compared to the same quarter last year. On average, analysts forecast that Sabra Healthcare REIT will post 1.52 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.20 dividend on an annualized basis and a yield of 6.0%. Sabra Healthcare REIT’s payout ratio is presently 461.54%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc is a real estate investment trust that owns and invests in healthcare-related properties. The company primarily focuses on skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals.

Sabra generally leases its properties to healthcare operators under long-term agreements, including triple-net leases, and may provide mortgage loans or other forms of financing to healthcare providers. Its portfolio serves healthcare markets across the United States and Canada.

Founded in 2010 and headquartered in Irvine, California, Sabra became a publicly traded company in 2010.